title: [Cutaneous leishmaniasis and multidermatomic herpes zoster].
abstract: Standard treatment of leishmaniasis consists of n-metilglucamine, meglumine antimoniate, which can trigger side effects such as general malaise, renal and hepatic impairment, and cardiac arrhythmias. Infrequently, reactivations of varicella-zoster virus infections have been reported. This paper describes a patient with cutaneous leishmaniasis in treatment with meglumine and herpes zoster multiplex. After ruling out other possible causes of immunosuppression, an acyclovir therapy was initiated.
authors: Margarita
authors: M
authors: Arboleda
authors: Laura
authors: L
authors: Jaramillo
authors: Diana
authors: D
authors: Ortiz
authors: Alejandro
authors: A
authors: Díaz
mesh_terms: D000328:Adult; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D005260:Female; D006562:Herpes Zoster / Q000139:chemically induced*; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008536:Meglumine / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000009:adverse effects*; D017193:Skin Diseases, Viral / Q000139:chemically induced* / Q000821:virology
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate